# A Randomized Trial of Cerclage Versus 17 α-Hydroxyprogesterone Caproate for Treatment of a Short Cervix

> **NCT00694967** · NA · TERMINATED · sponsor: **Lehigh Valley Hospital** · enrollment: 92 (actual)

## Conditions studied

- Mid Trimester Cervical Shortening

## Interventions

- **PROCEDURE:** McDonald cerclage placement
- **DRUG:** 17 hydroxyprogesterone caproate

## Key facts

- **NCT ID:** NCT00694967
- **Lead sponsor:** Lehigh Valley Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-11
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 92 (ACTUAL)
- **Why stopped:** Interim analysis showed no difference in outcome between treatment groups.
- **Last updated:** 2008-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00694967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00694967, "A Randomized Trial of Cerclage Versus 17 α-Hydroxyprogesterone Caproate for Treatment of a Short Cervix". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00694967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*